The five pharma companies have entered into a collaboration agreement, wherein the parties will jointly sponsor, supervise and monitor the clinical trial in India
BBIL had proposed to carry out Phase II/III clinical trial of Covaxin in the age group of 2 to 18 years
Bharat Biotech expects to share further details of the trial results as additional data become available.
Multi-target licensing agreement combines Stipple Bio’s epitope discovery platform with Lonza’s ADC technologies to develop targeted cancer treatments
Independent DSMB recommends continuation of Masupirdine without modifications as enrollment reaches 88% in global trial
Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term
Highlights potential for at-home heart attack risk assessment, offering a new approach to reducing treatment delays
The facility integrates advanced scientific infrastructure and specialised workflows to support complex drug delivery systems, sterile injectables, and differentiated dosage forms
The ventilator features a high-performance turbine capable of delivering up to 240 L/min peak flow
A total of 300 transgender individuals were screened as part of the study, with 82 identified as high-risk due to symptoms of anxiety, depression, and self-harm or suicidal tendencies
Subscribe To Our Newsletter & Stay Updated
